Abdominal and pelvic complications of molecular targeted therapy
Autor*in: |
Gore, Richard M [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Gore and Silvers; licensee BioMed Central Ltd. 2014 |
---|
Übergeordnetes Werk: |
Enthalten in: Cancer imaging - London, 2000, 14(2014), Suppl 1 vom: 09. Okt. |
---|---|
Übergeordnetes Werk: |
volume:14 ; year:2014 ; number:Suppl 1 ; day:09 ; month:10 |
Links: |
---|
DOI / URN: |
10.1186/1470-7330-14-S1-O37 |
---|
Katalog-ID: |
SPR03710182X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR03710182X | ||
003 | DE-627 | ||
005 | 20230519231946.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1470-7330-14-S1-O37 |2 doi | |
035 | |a (DE-627)SPR03710182X | ||
035 | |a (SPR)1470-7330-14-S1-O37-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gore, Richard M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Abdominal and pelvic complications of molecular targeted therapy |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Gore and Silvers; licensee BioMed Central Ltd. 2014 | ||
650 | 4 | |a Tumor Cell |7 (dpeaa)DE-He213 | |
650 | 4 | |a Growth Factor |7 (dpeaa)DE-He213 | |
650 | 4 | |a Tumor Size |7 (dpeaa)DE-He213 | |
650 | 4 | |a Growth Factor Receptor |7 (dpeaa)DE-He213 | |
650 | 4 | |a Treatment Response |7 (dpeaa)DE-He213 | |
700 | 1 | |a Silvers, Robert I |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer imaging |d London, 2000 |g 14(2014), Suppl 1 vom: 09. Okt. |w (DE-627)36374732X |w (DE-600)2104862-9 |x 1470-7330 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2014 |g number:Suppl 1 |g day:09 |g month:10 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/1470-7330-14-S1-O37 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 14 |j 2014 |e Suppl 1 |b 09 |c 10 |
author_variant |
r m g rm rmg r i s ri ris |
---|---|
matchkey_str |
article:14707330:2014----::boiaadevcopiainomlclr |
hierarchy_sort_str |
2014 |
publishDate |
2014 |
allfields |
10.1186/1470-7330-14-S1-O37 doi (DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e DE-627 ger DE-627 rakwb eng Gore, Richard M verfasserin aut Abdominal and pelvic complications of molecular targeted therapy 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Gore and Silvers; licensee BioMed Central Ltd. 2014 Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 Silvers, Robert I aut Enthalten in Cancer imaging London, 2000 14(2014), Suppl 1 vom: 09. Okt. (DE-627)36374732X (DE-600)2104862-9 1470-7330 nnns volume:14 year:2014 number:Suppl 1 day:09 month:10 https://dx.doi.org/10.1186/1470-7330-14-S1-O37 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2014 Suppl 1 09 10 |
spelling |
10.1186/1470-7330-14-S1-O37 doi (DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e DE-627 ger DE-627 rakwb eng Gore, Richard M verfasserin aut Abdominal and pelvic complications of molecular targeted therapy 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Gore and Silvers; licensee BioMed Central Ltd. 2014 Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 Silvers, Robert I aut Enthalten in Cancer imaging London, 2000 14(2014), Suppl 1 vom: 09. Okt. (DE-627)36374732X (DE-600)2104862-9 1470-7330 nnns volume:14 year:2014 number:Suppl 1 day:09 month:10 https://dx.doi.org/10.1186/1470-7330-14-S1-O37 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2014 Suppl 1 09 10 |
allfields_unstemmed |
10.1186/1470-7330-14-S1-O37 doi (DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e DE-627 ger DE-627 rakwb eng Gore, Richard M verfasserin aut Abdominal and pelvic complications of molecular targeted therapy 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Gore and Silvers; licensee BioMed Central Ltd. 2014 Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 Silvers, Robert I aut Enthalten in Cancer imaging London, 2000 14(2014), Suppl 1 vom: 09. Okt. (DE-627)36374732X (DE-600)2104862-9 1470-7330 nnns volume:14 year:2014 number:Suppl 1 day:09 month:10 https://dx.doi.org/10.1186/1470-7330-14-S1-O37 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2014 Suppl 1 09 10 |
allfieldsGer |
10.1186/1470-7330-14-S1-O37 doi (DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e DE-627 ger DE-627 rakwb eng Gore, Richard M verfasserin aut Abdominal and pelvic complications of molecular targeted therapy 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Gore and Silvers; licensee BioMed Central Ltd. 2014 Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 Silvers, Robert I aut Enthalten in Cancer imaging London, 2000 14(2014), Suppl 1 vom: 09. Okt. (DE-627)36374732X (DE-600)2104862-9 1470-7330 nnns volume:14 year:2014 number:Suppl 1 day:09 month:10 https://dx.doi.org/10.1186/1470-7330-14-S1-O37 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2014 Suppl 1 09 10 |
allfieldsSound |
10.1186/1470-7330-14-S1-O37 doi (DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e DE-627 ger DE-627 rakwb eng Gore, Richard M verfasserin aut Abdominal and pelvic complications of molecular targeted therapy 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Gore and Silvers; licensee BioMed Central Ltd. 2014 Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 Silvers, Robert I aut Enthalten in Cancer imaging London, 2000 14(2014), Suppl 1 vom: 09. Okt. (DE-627)36374732X (DE-600)2104862-9 1470-7330 nnns volume:14 year:2014 number:Suppl 1 day:09 month:10 https://dx.doi.org/10.1186/1470-7330-14-S1-O37 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2014 Suppl 1 09 10 |
language |
English |
source |
Enthalten in Cancer imaging 14(2014), Suppl 1 vom: 09. Okt. volume:14 year:2014 number:Suppl 1 day:09 month:10 |
sourceStr |
Enthalten in Cancer imaging 14(2014), Suppl 1 vom: 09. Okt. volume:14 year:2014 number:Suppl 1 day:09 month:10 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Tumor Cell Growth Factor Tumor Size Growth Factor Receptor Treatment Response |
isfreeaccess_bool |
true |
container_title |
Cancer imaging |
authorswithroles_txt_mv |
Gore, Richard M @@aut@@ Silvers, Robert I @@aut@@ |
publishDateDaySort_date |
2014-10-09T00:00:00Z |
hierarchy_top_id |
36374732X |
id |
SPR03710182X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03710182X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519231946.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1470-7330-14-S1-O37</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03710182X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1470-7330-14-S1-O37-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gore, Richard M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Abdominal and pelvic complications of molecular targeted therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Gore and Silvers; licensee BioMed Central Ltd. 2014</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Cell</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Size</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth Factor Receptor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silvers, Robert I</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Cancer imaging</subfield><subfield code="d">London, 2000</subfield><subfield code="g">14(2014), Suppl 1 vom: 09. Okt.</subfield><subfield code="w">(DE-627)36374732X</subfield><subfield code="w">(DE-600)2104862-9</subfield><subfield code="x">1470-7330</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:09</subfield><subfield code="g">month:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1470-7330-14-S1-O37</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2014</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">09</subfield><subfield code="c">10</subfield></datafield></record></collection>
|
author |
Gore, Richard M |
spellingShingle |
Gore, Richard M misc Tumor Cell misc Growth Factor misc Tumor Size misc Growth Factor Receptor misc Treatment Response Abdominal and pelvic complications of molecular targeted therapy |
authorStr |
Gore, Richard M |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)36374732X |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1470-7330 |
topic_title |
Abdominal and pelvic complications of molecular targeted therapy Tumor Cell (dpeaa)DE-He213 Growth Factor (dpeaa)DE-He213 Tumor Size (dpeaa)DE-He213 Growth Factor Receptor (dpeaa)DE-He213 Treatment Response (dpeaa)DE-He213 |
topic |
misc Tumor Cell misc Growth Factor misc Tumor Size misc Growth Factor Receptor misc Treatment Response |
topic_unstemmed |
misc Tumor Cell misc Growth Factor misc Tumor Size misc Growth Factor Receptor misc Treatment Response |
topic_browse |
misc Tumor Cell misc Growth Factor misc Tumor Size misc Growth Factor Receptor misc Treatment Response |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Cancer imaging |
hierarchy_parent_id |
36374732X |
hierarchy_top_title |
Cancer imaging |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)36374732X (DE-600)2104862-9 |
title |
Abdominal and pelvic complications of molecular targeted therapy |
ctrlnum |
(DE-627)SPR03710182X (SPR)1470-7330-14-S1-O37-e |
title_full |
Abdominal and pelvic complications of molecular targeted therapy |
author_sort |
Gore, Richard M |
journal |
Cancer imaging |
journalStr |
Cancer imaging |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
txt |
author_browse |
Gore, Richard M Silvers, Robert I |
container_volume |
14 |
format_se |
Elektronische Aufsätze |
author-letter |
Gore, Richard M |
doi_str_mv |
10.1186/1470-7330-14-S1-O37 |
title_sort |
abdominal and pelvic complications of molecular targeted therapy |
title_auth |
Abdominal and pelvic complications of molecular targeted therapy |
abstract |
© Gore and Silvers; licensee BioMed Central Ltd. 2014 |
abstractGer |
© Gore and Silvers; licensee BioMed Central Ltd. 2014 |
abstract_unstemmed |
© Gore and Silvers; licensee BioMed Central Ltd. 2014 |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
Suppl 1 |
title_short |
Abdominal and pelvic complications of molecular targeted therapy |
url |
https://dx.doi.org/10.1186/1470-7330-14-S1-O37 |
remote_bool |
true |
author2 |
Silvers, Robert I |
author2Str |
Silvers, Robert I |
ppnlink |
36374732X |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/1470-7330-14-S1-O37 |
up_date |
2024-07-03T21:08:18.911Z |
_version_ |
1803593605617549312 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03710182X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519231946.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1470-7330-14-S1-O37</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03710182X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1470-7330-14-S1-O37-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gore, Richard M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Abdominal and pelvic complications of molecular targeted therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Gore and Silvers; licensee BioMed Central Ltd. 2014</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Cell</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Size</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Growth Factor Receptor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silvers, Robert I</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Cancer imaging</subfield><subfield code="d">London, 2000</subfield><subfield code="g">14(2014), Suppl 1 vom: 09. Okt.</subfield><subfield code="w">(DE-627)36374732X</subfield><subfield code="w">(DE-600)2104862-9</subfield><subfield code="x">1470-7330</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:09</subfield><subfield code="g">month:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1470-7330-14-S1-O37</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2014</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">09</subfield><subfield code="c">10</subfield></datafield></record></collection>
|
score |
7.4011087 |